Evaluation of urate-lowering therapy in hyperuricemia patients: a systematic review and Bayesian network meta-analysis of randomized controlled trials

被引：0
|
作者：
Yu-Jiun Lin
Shiyng-Yu Lin
Chang-Hsien Lin
Sen-Te Wang
Shy-Shin Chang
机构：
[1] Taipei Medical University Hospital,Department of Family Medicine
[2] Taipei Medical University,Department of Family Medicine, School of Medicine, College of Medicine
[3] Taipei Medical University Hospital,Health Management Center
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Bayesian; Gout; Hyperuricemia; Meta-analysis; Urate-lowering therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1633 / 1648
页数：15
相关论文
共 50 条
  • [31] The effect of initiation of urate-lowering treatment during a gout flare on the current episode: a meta-analysis of randomized controlled trials
    Ertao Jia
    Xiaoling Yao
    Hongling Geng
    Li Zhong
    Jingjing Xie
    Yuya Xiao
    Yubao Jiang
    Xia Qiu
    Min Xiao
    Yanying Zhang
    Dabin Tang
    Jiaxin Wei
    Jianyong Zhang
    Advances in Rheumatology, 62
  • [32] Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis
    Maher, Dorsa
    Reeve, Emily
    Hopkins, Ashley
    Tan, Jiun Ming
    Tantiongco, Mahsa
    Ailabouni, Nagham
    Woodman, Richard
    Stamp, Lisa
    Bursill, David
    Proudman, Susanna
    Wiese, Michael
    ARTHRITIS CARE & RESEARCH, 2024, 76 (06) : 871 - 881
  • [33] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao Li
    Cao Ling
    Zhao Tian-Yi
    Yang Xue
    Zhu Xiao-Xia
    Zou He-Jian
    Wan Wei-Guo
    Xue Yu
    中华医学杂志英文版, 2020, 133 (08) : 982 - 993
  • [34] The effect of initiation of urate-lowering treatment during a gout flare on the current episode: a meta-analysis of randomized controlled trials
    Jia, Ertao
    Yao, Xiaoling
    Geng, Hongling
    Zhong, Li
    Xie, Jingjing
    Xiao, Yuya
    Jiang, Yubao
    Qiu, Xia
    Xiao, Min
    Zhang, Yanying
    Tang, Dabin
    Wei, Jiaxin
    Zhang, Jianyong
    ADVANCES IN RHEUMATOLOGY, 2022, 62 (01)
  • [35] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao, Li
    Cao, Ling
    Zhao, Tian-Yi
    Yang, Xue
    Zhu, Xiao-Xia
    Zou, He-Jian
    Wan, Wei-Guo
    Xue, Yu
    CHINESE MEDICAL JOURNAL, 2020, 133 (08) : 982 - 993
  • [36] Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
    Isabel Castrejon
    Esther Toledano
    María Piedad Rosario
    Estíbaliz Loza
    Fernando Pérez-Ruiz
    Loreto Carmona
    Rheumatology International, 2015, 35 : 1127 - 1137
  • [37] Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials
    Yang, Xiu Hong
    Zhang, Bao Long
    Cheng, Yun
    Fu, Shun Kun
    Jin, Hui Min
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [38] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S21 - S22
  • [39] Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review
    Virginie Beslon
    Perrine Moreau
    Annabel Maruani
    Hubert Maisonneuve
    Bruno Giraudeau
    Jean-Pascal Fournier
    Journal of General Internal Medicine, 2018, 33 : 358 - 366
  • [40] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S54 - S54
12345